3-113291738-A-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001164496.2(CFAP44):āc.5384T>Cā(p.Phe1795Ser) variant causes a missense change. The variant allele was found at a frequency of 0.000174 in 1,535,754 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (no stars).
Frequency
Genomes: š 0.00021 ( 0 hom., cov: 32)
Exomes š: 0.00017 ( 0 hom. )
Consequence
CFAP44
NM_001164496.2 missense
NM_001164496.2 missense
Scores
1
6
10
Clinical Significance
Conservation
PhyloP100: 5.04
Genes affected
CFAP44 (HGNC:25631): (cilia and flagella associated protein 44) Enables peptidase activity. Involved in sperm axoneme assembly. Acts upstream of or within microtubule cytoskeleton organization. Predicted to be located in cytoplasm; cytoskeleton; and motile cilium. Implicated in spermatogenic failure 20. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.36239797).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CFAP44 | NM_001164496.2 | c.5384T>C | p.Phe1795Ser | missense_variant | 35/35 | ENST00000393845.9 | |
LOC127898559 | NR_183046.1 | n.8020T>C | non_coding_transcript_exon_variant | 48/48 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CFAP44 | ENST00000393845.9 | c.5384T>C | p.Phe1795Ser | missense_variant | 35/35 | 5 | NM_001164496.2 | P2 | |
CFAP44 | ENST00000484923.1 | n.516T>C | non_coding_transcript_exon_variant | 2/2 | 4 | ||||
CFAP44 | ENST00000461734.1 | c.*74T>C | 3_prime_UTR_variant, NMD_transcript_variant | 10/10 | 2 | ||||
CFAP44 | ENST00000489244.1 | c.*307T>C | 3_prime_UTR_variant, NMD_transcript_variant | 4/4 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000210 AC: 32AN: 152194Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
32
AN:
152194
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000240 AC: 35AN: 145702Hom.: 0 AF XY: 0.000116 AC XY: 9AN XY: 77478
GnomAD3 exomes
AF:
AC:
35
AN:
145702
Hom.:
AF XY:
AC XY:
9
AN XY:
77478
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000170 AC: 235AN: 1383560Hom.: 0 Cov.: 34 AF XY: 0.000157 AC XY: 107AN XY: 682688
GnomAD4 exome
AF:
AC:
235
AN:
1383560
Hom.:
Cov.:
34
AF XY:
AC XY:
107
AN XY:
682688
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000210 AC: 32AN: 152194Hom.: 0 Cov.: 32 AF XY: 0.000229 AC XY: 17AN XY: 74356
GnomAD4 genome
AF:
AC:
32
AN:
152194
Hom.:
Cov.:
32
AF XY:
AC XY:
17
AN XY:
74356
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
4
ExAC
AF:
AC:
4
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
CFAP44-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 12, 2024 | The CFAP44 c.5384T>C variant is predicted to result in the amino acid substitution p.Phe1795Ser. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.058% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Vest4
MutPred
Gain of relative solvent accessibility (P = 0.0104);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at